Background {#Sec1}
==========

Multiple myeloma (MM) originates in neoplastic plasma cell disorder, and it is characterized by the clonal proliferation of malignant plasma cells in the bone marrow. As the second most general hematological cancer, the incidence of MM worldwide is about 1.5/100,000 new case \[[@CR1]\]. It is also found that the incidence of MM is higher in men than in women, as well as in black than white in the USA \[[@CR2]\]. MM is always associated with organ dysfunction, especially osteolysis \[[@CR3]\]. Although the survival rate of MM patients is increased due to the advanced medicines \[[@CR4]\], MM continues to be considered as an incurable disease, and further study is required to fully understand the potential molecular mechanisms of osteolysis in MM patients.

To adopt a volume appropriate for the local environment, the bone continuously remodels to keep the balance between bone formation and resorption mediated by osteocytes, osteoblasts, and osteoclasts \[[@CR5]\]. Osteocyte represents the most abundant cell type in the bone and is actively involved in bone turnover. Dickkopf 1(*DKK1*) levels increase in the peripheral blood and bone marrow plasma of MM patients and relate to the development of osteolytic lesions \[[@CR6], [@CR7]\]. Tumor necrosis factor-related apoptosis-inducing ligand (*TRAIL*) produced by myeloma cells is positively correlated with osteolytic markers (such as urinary deoxypyridinoline and serum calcium), indicating that *TRAIL* may function in osteolysis of MM patients \[[@CR8]\]. Via promoting the expression of receptor activator of NF-kB (*RANK*) in osteoclast precursors, c-Akt (*AKT*) plays a role in the osteoclast formation and bone osteolysis induced by MM \[[@CR9]\]. Giuliani et al. found that MM cells promoted osteocyte death and altered the transcriptional profile in osteocyte \[[@CR10]\]. However, they did not further perform comprehensive bioinformatics analysis to investigate the internal causes. In spite of the above researches, the molecular mechanism of the increased osteocyte death in MM patients is still unclear.

In our study, in order to investigate the molecular mechanism of osteocyte death in MM patients, we reanalyzed the gene expression profile in Giuliani et al. study and identified the differentially expressed genes (DEGs) between normal osteocytes and osteocytes affected by MM cells. The enriched functions and pathways of DEGs were further identified. In addition, we constructed the protein-protein interaction (PPI) network of DEGs. Then, the most significant sub-network was screened out.

Methods {#Sec2}
=======

Affymetrix microarray data {#Sec3}
--------------------------

Gene transcriptional profile of GSE27372 \[[@CR10]\] was downloaded from Gene Expression Omnibus (GEO) database (<https://www.ncbi.nlm.nih.gov/geo/>), and GSE27372 was based on the platform of GPL570 \[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 array. There were six specimens in this dataset, including three HOB-01 (osteocyte cell line) control samples and three HOB-01 samples co-cultured with JJN3 (human myeloma cell line).

DEGs screening {#Sec4}
--------------

AFFY package (version 1.28.0, <http://www.bioconductor.org/packages/release/bioc/html/affy.html>) of Bioconductor \[[@CR11]\] was used to pre-process the Affymetrix microarray data. All raw data were scaled according to the robust multi-array average (RMA) method \[[@CR12]\] with default settings. After background correction, quantile normalization, and probe summarization, the gene expression matrix was obtained. The Student's *t* test method \[[@CR13]\] was adopted to analyze the expression differences between control and co-culture group. For each significant DEG, both *P* value \<0.05 and \|log~2~ fold change (FC)\| \>0.58 need to be met.

Function and pathway enrichment analyses of DEGs {#Sec5}
------------------------------------------------

Functional annotation for DEGs was performed by Gene Ontology \[[@CR14]\]. Kyoto Encyclopedia of Genes and Genomes (KEGG <http://www.genome.jp/kegg/pathway.html>) pathway enrichment analysis was used to identify main functional and metabolic pathways involving DEGs. We used *P* value \<0.01 as the cut-off criterion for the enrichment analysis which was conducted by the Database for Annotation, Visualization and Integrated Discovery (DAVID; version 2.1b, <http://david.abcc.ncifcrf.gov/>) online software \[[@CR15]\].

Transcription factors (TFs) and tumor-associated genes (TAGs) in DEGs {#Sec6}
---------------------------------------------------------------------

DEGs with the function of transcriptional regulation, namely, differentially expressed transcription factors were selected based on the TRANSFAC database (<http://www.gene-regulation.com/pub/databases.html>) \[[@CR16]\]. According to the TSGene database ([http://bioinfo.mc.vanderbilt.edu/TSGene/search.cgi](http://bioinfo.mc.vanderbilt.edu/TSGene/search.cgi))) \[[@CR17]\] and TAG database ([http://www.binfo.ncku.edu.tw/TAG/](http://www.binfo.ncku.edu.tw/TAG/))) \[[@CR18]\], we extracted the TAGs from DEGs, including tumor suppressor genes and oncogenes.

Construction of PPI network and sub-network {#Sec7}
-------------------------------------------

The interaction pairs of DEGs were analyzed via online tool Search Tool for the Retrieval of Interacting Genes (STRING; version 9.0, <http://string-db.org>) \[[@CR19]\], and interaction data were downloaded on June 27, 2014. Only the gene pairs which were recorded in database, and experimental validated, text-mined, or co-expressed were used and combined score \>0.4 was set as the criterion of PPI. Then, the PPI network was constructed using Cytoscape (version 2.8, <http://cytoscape.org>) \[[@CR20]\].

The sub-network analysis of PPI network was performed using the ClusterONE plug of Cytoscape \[[@CR21]\]. The pathway enrichment analysis of the genes in the most significant sub-network was performed by using the DAVID online software \[[@CR15]\].

Results {#Sec8}
=======

MM-induced DEGs in osteocytes {#Sec9}
-----------------------------

After analyzing the microarray data of control and co-culture groups, a total of 393 DEGs were screened out, including 167 down-regulated genes and 226 up-regulated genes in co-culture group.

Functions and pathways enriched by DEGs {#Sec10}
---------------------------------------

To explore the specific functions and pathways of DEGs, functional and pathway enrichment analyses were performed. The down-regulated genes were most significantly enriched in the functions of cardiovascular system development, circulatory system development (Table [1](#Tab1){ref-type="table"}), and the pathways of protein digestion, absorption, and extracellular matrix (ECM)-receptor interaction pathway (Table [2](#Tab2){ref-type="table"}). Especially, epidermal growth factor (*EGF*), sphingosine-1-phosphate receptor 1 (*S1PR1*), and Neuropeptide Y1 receptor (*NPY1R*) were involved in circulatory system development. Moreover, the up-regulated genes were most significantly enriched in the functions of regulation of response to stimulus and regulation of signaling function (Table [1](#Tab1){ref-type="table"}), as well as the pathways of JAK-STAT signaling, nicotinate, and nicotinamide metabolism (Table [2](#Tab2){ref-type="table"}).Table 1Function enrichment analysis of DEGsCategoryGO IDGO termGene count*P* valueDownGO:0072358Cardiovascular system development352.22E-15DownGO:0072359Circulatory system development352.22E-15DownGO:0048731System development731.24E-14DownGO:0009653Anatomical structure morphogenesis551.44E-14DownGO:0031012Extracellular matrix195.70E-09DownGO:0005583Fibrillar collagen53.72E-08DownGO:0044420Extracellular matrix part125.72E-08DownGO:0005201Extracellular matrix structural constituent92.38E-08DownGO:0005178Integrin binding85.43E-07DownGO:0005198Structural molecule activity185.64E-06UPGO:0048583Regulation of response to stimulus675.57E-11UPGO:0023051Regulation of signaling592.48E-10UPGO:0010646Regulation of cell communication592.71E-10UPGO:0023052Signaling972.82E-10UPGO:0005615Extracellular space201.72E-03UPGO:0044421Extracellular region part242.83E-03UPGO:0031095Platelet dense tubular network membrane24.40E-03UPGO:0043565Sequence-specific DNA binding215.35E-05UPGO:0000982RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity71.95E-04UPGO:0003700Sequence-specific DNA binding transcription factor activity253.44E-04*GO* gene ontology; *ID* identifier; *DEGs* differentially expressed genesTable 2Pathway enrichment analysis of DEGsCategoryKEGG pathwayGene count*P* valueDownProtein digestion and absorption61.44E-04DownECM-receptor interaction61.88E-04DownAmoebiasis66.24E-04DownFocal adhesion87.86E-04DownRegulation of actin cytoskeleton81.19E-03DownAxon guidance61.74E-03DownMelanoma45.42E-03DownHypertrophic cardiomyopathy (HCM)49.38E-03UpJAK-STAT signaling pathway123.08E-06UpNicotinate and nicotinamide metabolism44.16E-04UpCalcium signaling pathway85.14E-03UpVEGF signaling pathway55.68E-03UpPhosphatidylinositol signaling system56.34E-03UpCytokine-cytokine receptor interaction106.46E-03*KEGG* Kyoto Encyclopedia of Genes and Genomes; *DEGs* differentially expressed genes

Differentially expressed TFs and TAGs {#Sec11}
-------------------------------------

The TFs and TAGs differentially expressed between control and co-culture groups were further extracted from DEGs. As shown in Table [3](#Tab3){ref-type="table"}, four down-regulated TFs and 18 up-regulated TFs (e.g., Krüppel-like factors 4, *KLF4*; and IFN regulatory factor-8, *IRF8*) were discovered.Table 3Differentially expressed TFs and TAGsRegulationTF countsTFsTAG countsOncogenesTumor suppressor genesOther TAGsDown4TGFB1I1, NKX2-2, KLF5, ID216RUNX1T1, PDGFRB, CD24TPM1, SPTBN1,PRICKLE1, KLF5, IGFBP3, FAT4,EFNA1, DNAJB4, DAB2, CADM1TGFB2, LRRC17, BAMBIUp18SOX9, SOX7, NR3C2, MSX1, MAFF, KLF4, JUNB, IRF8, HOXB6, HMGA2, HES1, OXF1, FOXA2, ETV5, ETV4, ELK3, EGR3, EGR121VEGFA, SPHK1, PDGFRA, JUNB, HMGA2, FOSL1, FGF5, ETV1, CCND1SPRY2, SOX7, IRF8, IL24, HOPX, FOXA2, EPHB2, ENC1, EGR1, DUSP6KLF4, EMP1*TF(s)* transcription factor(s); *TAG(s)* tumor-associated gene(s)

Furthermore, 16 down-regulated TAGs and 21 up-regulated TAGs were screened out (Table [3](#Tab3){ref-type="table"}). Among the down-regulated TAGs, there were 10 tumor suppressor genes and 3 oncogenes. Meanwhile, among the up-regulated TAGs, there were 10 tumor suppressor genes (e.g. *IRF8*) and 9 oncogenes.

Construction of PPI network and sub-network {#Sec12}
-------------------------------------------

Interactions between DEGs were identified using STRING software. By integrating DEG pairs with combined score \>0.4, a PPI network was built (Fig. [1](#Fig1){ref-type="fig"}), consisting of 89 down-regulated genes and 113 up-regulated genes. A total of 10 DEGs had connectivity degree larger than 15, e.g., EGF (degree = 31) and early growth response 1 (EGR1, degree = 19). Besides, EGF could interact with EGR1 in the PPI network.Fig. 1Protein-protein interaction (PPI) network of differentially expressed genes (DEGs). *Red* and *green nodes* represent up-regulated genes and down-regulated genes, respectively

Moreover, a sub-network was obtained from PPI network (*P* value = 0.0004.3) (Fig. [2](#Fig2){ref-type="fig"}), consisting of nine significant DEGs like S1PR1, complement-3a receptor1 (C3AR1), and NPY1R. In the sub-network, S1PR1, C3AR1, and NPY1R had interactions with each other. Furthermore, the up-regulated *C3AR1*, as well as the down-regulated *S1PR1* and *NPY1R* in the sub-network were enriched in the neuroactive ligand-receptor interaction pathway (Table [4](#Tab4){ref-type="table"}).Fig. 2Sub-network in the protein-protein interaction (PPI) network of differentially expressed genes (DEGs). *Red* and *green nodes* stand for up-regulated genes and down-regulated genes, respectivelyTable 4Pathways enriched by the genes in sub-networkKEGG pathwayGene count*P* valueGenesNeuroactive ligand-receptor interaction31.42E-02C3AR1, S1PR1, NPY1R*KEGG* Kyoto Encyclopedia of Genes and Genomes

Discussion {#Sec13}
==========

To gain insight into the molecular mechanisms of the myeloma-induced osteocyte death, gene expression profiles in osteocytes co-cultured with or without myeloma cells were systematically analyzed here. A total of 226 up-regulated genes and 167 down-regulated genes were identified. Then, PPI network was constructed, and sub-network was identified.

TFs like *KLF4* and *IRF8* were up-regulated in osteocytes co-cultured with myeloma cells in comparison with osteocytes cultured alone. Previous study reported that *KLF4* expression is essential for blocking cell cycle and increasing the resistance of MM cells to alkylating agents \[[@CR22]\]. As one of the Yamanaka reprogramming factors and TFs, *KLF4* can promote the expression of autophagy-related genes \[[@CR23]\]. In addition, silencing of the interferon consensus sequence-binding protein (*ICSBP/IRF8*) gene may be induced by DNA methylation or other mechanisms and correlates with the malignant phenotype of MM \[[@CR24]\]. In our study, *KLF4* and *IRF8* were up-regulated TFs, and *IRF8* was a tumor suppressor gene. These suggested that *KLF4* and *IRF8* might play a role in osteolysis in MM patients.

In this study, EGF and EGR1 had high connectivity degrees in PPI network. A heparin-binding factor in EGF family, amphiregulin (*AREG*) is overexpressed in primary myeloma cells and can promote growth of bone marrow stromal cell \[[@CR25]\]. *EGR-1* induces apoptosis in MM via interacting with *JUN*, and decreased *JUN/EGR-1* can enhance resistance of MM cells to bortezomib \[[@CR26]\]. Functional enrichment indicated that *EGF* was involved in circulatory system development. It has been reported that the substances of the circulatory system can induce the apoptosis of tumor cells \[[@CR27]\]. EGF could interact with EGR1 in the PPI network, indicating that *EGF* and *EGR1* might be involved in osteocytes apoptosis induced by MM cells through interacting with each other.

Enrichment analysis suggested that *S1PR1*, *C3AR1*, and *NPY1R* in sub-network were enriched in the pathway of neuroactive ligand-receptor interaction, meanwhile *S1PR1* and *NPY1R* were involved in the function of circulatory system development. S1PR1 is a G-protein-coupled receptor which binds to the bioactive signaling molecule sphingosine 1-phosphate (S1P) \[[@CR28]\]. It is reported that *S1PR1* and *S1PR2* regulate osteoclast precursor migration between the bone marrow cavities and the circulation \[[@CR29]\]. It is shown that component 3 (C3A) and its receptor C3AR play a role in osteoclast formation \[[@CR30], [@CR31]\], implying a potential role of *C3AR* in osteocyte death. Thus, *S1PR1* and *C3AR1* may promote the death of osteocytes, and this is consistent with the finding of Giuliani et al. \[[@CR10]\]. *NPY1R* is a receptor of neuropeptide Y (*NPY*), which is a neurotransmitter. There is evidence that *NPY* regulates bone homeostasis via actions in peripheral tissues \[[@CR32]\]. *NPY1R* is the only Y receptor which is robustly expressed in bone marrow stromal cells \[[@CR33]\] and osteoblasts \[[@CR34]\], implying a direct role of *NPY1R* in bone remodeling. In addition, the absence of peripheral Y1 receptor will lead to pronounced anabolic effects on the bone \[[@CR35]\]. Here, *NPY1R* was significantly down-regulated in osteocytes co-cultured with myeloma cells, inhibiting bone remodeling. In the sub-network, S1PR1, C3AR1, and NPY1R had interactions with each other, suggesting that *S1PR1*, *C3AR1*, and *NPY1R* might function in osteocytes apoptosis induced by MM cells via interactions.

Conclusions {#Sec14}
===========

In conclusion, a total of 393 DEGs were identified between osteocytes co-cultured with and without myeloma cells, and *KLF4*, *IRF8*, *EGF*, *EGR1*, *S1PR1*, *C3AR1*, and *NPY1R* might be involved in osteocyte cell apoptosis induced by MM cells. Here, we studied the potential molecular mechanism of the increased osteocyte death, which may provide a theoretical basis for understanding and treatment of osteolysis in MM patients. However, the present study analyzed gene expression data generated from not primary cells isolated from myeloma patients and healthy controls but cell lines, and the sample size was small. Thus, confirmation of results by quantitative real-time polymerase chain reaction (qRT-PCR) in cell lines followed by the investigation of the roles and functions of candidate genes in cells isolated from MM patients and healthy controls is still needed.
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